Swiss Scientists Uncover Evidence That Avandia Increases Bone Fracture Risk in Patients

June 11th, 2008 | Category: General Health

Swiss researchers recently concluded that Avandia, a type 2 diabetes drug, nearly doubles the chances of osteoporosis and bone fracture among patients who take the drug and is increased for patients taking the drug for more than a

year. The results of the study come on heels of controversy surrounding the drug’s link to increased heart disease and various studies warning of potential risks related to bone degradation.

Original post by syndicate@legalview.com (Alan Haburchak)

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.